Risedronate and leukopenia Patient Reports February 12, 2012

Risedronate Side Effects Report #6081459-3
Risedronate side effect was reported by a Physician from JAPAN on Feb 02, 2009. Female patient, 80 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: escherichia urinary tract infection, febrile neutropenia, inflammation, leukopenia, sepsis , tremor. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ALFAROL, SANACTASE, CARVEDILOL, DEPAS. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5786746-1
Risedronate side effect was reported by a Health Professional from JAPAN on June 04, 2008. Female patient, 62 years of age, was diagnosed with osteoporosis , rheumatoid arthritis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: condition aggravated, leukopenia, urticaria. Risedronate dosage: 2.5 MG ONCE DAILY, ORAL; 2.5 MG ONCE DAILY, ORAL. During the same period patient was treated with CELECOXIB, LANSOPRAZOLE, MEDROL, ZOLPIDEM TARTRATE, ONEALFA, MUCOSTA. Patient recovered.

Risedronate Side Effects Report #5818980-6
Risedronate side effect was reported by a Health Professional from JAPAN on July 02, 2008. Female patient, 62 years of age, was diagnosed with osteoporosis , rheumatoid arthritis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: condition aggravated, discomfort, leukopenia, pain , urticaria. Risedronate dosage: 2.5 MG ONCE DAILY, ORAL; 2.5 MG ONCE DAILY, ORAL. During the same period patient was treated with CELECOXIB, LANSOPRAZOLE, MEDROL, ZOLPIDEM TARTRATE, ONEALFA, MUCOSTA, RIMATIL. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5485937-7
Risedronate side effect was reported by a Physician from JAPAN on Sept 27, 2007. Male patient, 60 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, leukopenia, platelet count decreased, pyrexia, red blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with PREDNISONE, LORFENAMIN, MUCOSTA, SULFAMETHOXAZOLE, VITAMEDIN. Patient was hospitalized. Patient recovered.


Risedronate Side Effects Report #4956815-4
Risedronate side effect was reported by a Physician from JAPAN on Mar 07, 2006. Female patient, 24 years of age, was diagnosed with osteoporosis , ulcer  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: granulocytopenia, leukopenia, lymphocyte count increased, lymphocyte percentage decreased, neutropenia. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with STOGAR, ALFAROL, GASTROM, PREDNISOLONE. Patient recovered.